Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-03

Clinical Trial Update: On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

View source ↗

Summary

Sponsored by the Medical University of Vienna, the trial investigated the impact of TNF-alpha inhibition on anogenital HPV infection in people with psoriasis or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNF-alpha inhibitors (class)

Snippet

Sponsor: Medical University of Vienna | Conditions: Psoriasis, Inflammatory Bowel Diseases | Status: COMPLETED